A mutation of POLE, DNA polymerase ε, which has polymerase activity and 3′-5′ exonuclease activity, along with MMR deficiency, will cause a high tumor mutation burden, resulting in the accumulation of mutated genes in cells and the production of tumor neoantigens. The gene discussed is MRC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.